Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular diclofenac to prevent post-ERCP pancreatitis
KCT0001175Phase 3Recruiting
- Sponsor
- Yeungnam University Medical Center
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diclofenac in post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP), sponsored by Yeungnam University Medical Center. Started May 2014; status: recruiting.
02
Drugs
diclofenac
03
Conditions
post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP)
Beyond the preview
Go deeper on KCT0001175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001175.